02/08/2021

NSAIDs and COVID-19: A Systematic Review and Meta-analysis

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been discouraged for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, fearing that they could increase the risk of infection or the severity of SARS-CoV-2.

Matéria original

Anterior

Anti-SARS-CoV-2 and anti-cytokine storm neutralizing antibody therapies against COVID-19: Update, challenges, and perspectives
Próxima

S100A8 may govern hyper-inflammation in severe COVID-19